Medical Developments International | MVP - Beneficio Operativo

Precio De Mercado
0.43
Cambio Diario
-0.01 -1.16%
Mensual
-10.53%
Anual
-31.45%
Q1 Expectativa
0.43




Beneficio Operativo Cambio Fecha
Akebia Therapeutics USD 13.51M 27.82M 2025-03
Alaunos Therapeutics USD -1.19M 432K 2025-09
Avita Medical AUD -10.41M 742K 2025-12
Clinuvel Pharmaceuticals AUD 39.05M 21.49M 2024-06
Dianthus Therapeutics USD -40.29M 5.36M 2025-09
Genetic Signatures AUD -6.34M 8.82M 2025-12
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
Medical Developments International AUD -36K 444K 2025-12
Neuren Pharmaceuticals AUD 17.01M 11.56M 2025-12
Organon & Co USD 388M 62M 2025-09
Paradigm Biopharmaceuticals AUD -8.5M 2.57M 2025-06
PYC Therapeutics AUD -22.59M 9.12M 2025-12
Starpharma Holdings AUD -873K 1.43M 2025-12
Tectonic Therapeutic USD -21.89M 440K 2025-09
Telix Pharmaceuticals AUD 8.04M 3.21M 2025-12
Viatris USD -157.5M 392M 2025-12
Xeris Pharmaceuticals USD 6.73M 2.25M 2025-09